Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Accidental actinomycin D overdosage in man, a case report.

I A Choonara1, S Kendall-Smith, C C Bailey

  • 1Department of Paediatrics and Child Health, St. James's University Hospital, Leeds, England.

Cancer Chemotherapy and Pharmacology
|January 1, 1988
PubMed
Summary

Actinomycin D overdose is rare but can occur. This case highlights the need for better understanding of its toxicity in humans, especially compared to newer drugs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ulcerative cheilitis in a rhesus macaque.

Veterinary pathology·2011
Same author

Response to Bunce et al. Causes of blind and partial sight certifications in England and Wales: April 2007-March 2008.

Eye (London, England)·2011
Same author

Diabetic nocturnal diarrhea.

Journal of the American Medical Association·2010
Same author

Nonarteritic anterior ischaemic optic neuropathy in Addison's disease.

Eye (London, England)·2010
Same author

A randomised prospective double-masked exploratory study comparing combination photodynamic treatment and intravitreal ranibizumab vs intravitreal ranibizumab monotherapy in the treatment of neovascular age-related macular degeneration.

Eye (London, England)·2010
Same author

Ovarian pathology in rhesus macaques: a 12-year retrospective.

Journal of medical primatology·2010

Area of Science:

  • Oncology
  • Pharmacology
  • Toxicology

Background:

  • Actinomycin D is an established cytotoxic chemotherapy agent.
  • Limited human toxicity data exists for Actinomycin D compared to newer agents.
  • Understanding drug toxicity is crucial for patient safety in cancer treatment.

Observation:

  • A case of inadvertent Actinomycin D overdose is presented.
  • The specific circumstances leading to the overdose are detailed.
  • This highlights a potential gap in medication safety protocols.

Findings:

  • The clinical presentation and management of the Actinomycin D overdose.
  • Analysis of the patient's response to the overdose.
  • Comparison of observed toxicity with known toxicological profiles.

Related Experiment Videos

Implications:

  • Reinforces the importance of careful dosing and administration of cytotoxic agents.
  • Suggests a need for further research into Actinomycin D's human toxicity.
  • Informs clinical practice regarding management of chemotherapy overdoses.